Swine Flu Vaccine Trials begin–160M Shots ordered
…an aggressive campaign to vaccinate against the swine flu–EVEN BEFORE THE VACCINE’S SAFETY HAS BEEN TESTED, or the safety of the vaccine adjuvants have been tested.
Is the Schizophrenia Mortality Study in The Lancet CREDIBLE?
Unless the overall treatment and services provided to schizophrenia patients in Finland is unique and especially protective—which the authors do not suggest—their claimed findings of lowered mortality rates for antipsychotic drug users are belied by a consistent body of evidence.
Psychiatrist Steps to the Plate
Motherhood is NOT a Medical Disorder Stop: Mother’s Act
World Conference Science Journalists
So far as I can tell, the panel that I was asked to participate in was the only one that focused on the pharmaceutical industry.
Separating Science from Promotion, Evidence from Propaganda WCSJ 2009
Click here for Separating Science from Promotion, Evidence from Propaganda
Medtronic Paid the Surgeon Accused Of Falsifying Study Nearly $800,000
Medtronic acknowledged that some of the consulting payments occurred during the time that Dr. Kuklo, was shopping his favorable study of Medtronic’s Infuse bone-graft product to medical journals.
Gene Theory for Depression Is Now Discredited
The study, reported in The Journal of the American Medical Association, "found no evidence of an association between the serotonin gene and the risk of depression, no matter what people’s life experience was."
Children Rx ADHD Drugs 7.4 times increased risk of sudden death
But FDA says keep taking the "medicines."
Did FDA Include Evidence of Brain Damage Caused by Antipsychotics?
Among the most damaging scientific evidence against the use of antipsychotic drugs is empirical evidence that they cause brain damage.
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
Marketing Trumps Safety: the case of Antipsychotics
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
USA Today: Conflicts of interest bedevil psychiatric drug research
Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay.